China Medical & HealthCare Group Limited reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was HKD 3.32 million compared to HKD 3.04 million a year ago. Revenue was HKD 736.02 million compared to HKD 708.67 million a year ago.

Net loss was HKD 43.9 million compared to HKD 73.9 million a year ago. Basic loss per share from continuing operations was HKD 0.06 compared to HKD 0.102 a year ago.